The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASCO 2021 | Real-world molecular characterization of SCLC subtypes
Sonam Puri, MD, Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT, discusses the findings of a large-scale analysis of real-world small cell lung cancer (SCLC) patient samples, examining the expression of clinically relevant biomarkers across subtypes. Differential expression across SCLC subtypes may inform personalized treatment approaches. This interview took place at the American Society of Clinical Oncology (ASCO) 2021 Virtual Meeting.
